Day: May 28, 2025

Advanz Pharma secures exclusive rights from Alvotech to commercialize three biosimilar candidates in Europe in addition to previously partnered programsThe agreement includes proposed biosimilars to Ilaris® (canakinumab), Kesimpta® (ofatumumab) and an additional early-stage undisclosed biosimilar candidateREYKJAVIK, Iceland and LONDON, May 28, 2025 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma, a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines in Europe, today announced that the companies have entered into an agreement to expand their commercial partnership to cover three additional biosimilar candidates. The new agreement...

Company announcement Management changes in the Nykredit GroupIn connection with Spar Nord Bank A/S becoming part of the Nykredit Group, changes are expected to be made to the boards of directors and executive managements of the companies in the Nykredit Group. Lasse Nyby to become Deputy Chairman of Nykredit A/S and Nykredit Realkredit A/SOn Monday, 2 June, 2025, a general meeting in Nykredit Realkredit A/S is expected to be convened, to be held on 24 June, 2025, at which it is proposed that Lasse Nyby – the current CEO of Spar Nord Bank A/S – joins the Board of Directors of Nykredit Realkredit A/S. Lasse Nyby will continue on the Board of Directors of Nykredit A/S, which he has been a member of since 2007. Lasse Nyby is expected to be appointed Deputy Chairman of the two boards at the following board meetings. Preben Sunke will...

Company announcement Management changes in the Nykredit GroupIn connection with Spar Nord Bank A/S becoming part of the Nykredit Group, changes are expected to be made to the boards of directors and executive managements of the companies in the Nykredit Group. Lasse Nyby to become Deputy Chairman of Nykredit A/S and Nykredit Realkredit A/SOn Monday, 2 June, 2025, a general meeting in Nykredit Realkredit A/S is expected to be convened, to be held on 24 June, 2025, at which it is proposed that Lasse Nyby – the current CEO of Spar Nord Bank A/S – joins the Board of Directors of Nykredit Realkredit A/S. Lasse Nyby will continue on the Board of Directors of Nykredit A/S, which he has been a member of since 2007. Lasse Nyby is expected to be appointed Deputy Chairman of the two boards at the following board meetings. Preben Sunke will...

Company announcement no. 17Management changes in Spar Nord Bank A/SAgreements have been reached regarding the step down of Lasse Nyby and John Lundsgaard In continuation of the completed voluntary takeover offer from Nykredit Realkredit A/S (Nykredit), whereby Nykredit acquired the majority shareholding in Spar Nord Bank A/S (Spar Nord), agreements have been entered into with the board of directors of Spar Nord, whereby Lasse Nyby will resign as CEO of Spar Nord and John Lundsgaard as managing director of Spar Nord. Lasse Nyby and John Lundsgaard will both resign from Spar Nord’s executive board no later than on 30 June 2025. Kjeld Johannesen, chairman of Spar Nord’s board of directors, says: “The agreed resignation is a natural extension of Nykredit’s acquisition of the majority shareholding in Spar Nord...

Allschwil, Switzerland – May 28, 2025At today’s Annual General Meeting (AGM) of Idorsia Ltd (SIX: IDIA) held in Basel, Switzerland, shareholders voted convincingly in favor of all proposals by the Board of Directors. The meeting was attended by 166 shareholders, representing a total of 97’748’740 shares, or 43.28% of the total outstanding shares. Led by the Chairman of the Board, Jean-Paul Clozel the company presented a business update. Jean-Paul Clozel, MD, Chairman of the Board of Directors, commented:“On behalf of the Board, I would like to thank the shareholders for their support and loyalty. I strongly believe that with their backing, with our products and pipeline, and with our people working to ramp-up the sales of QUVIVIQ and activate the pipeline, Idorsia can become one of the most successful biotech companies in Europe.” The...

Today, the Chairman of the Board and the CEO of Kvika banki hf. received a letter from Íslandsbanki hf. requesting to enter into merger discussions. The Board of Directors of Kvika banki hf. will review the matter and determine the bank’s next steps. Please note that this notice is a disclosure of inside information per article 7 of regulation (EU) No 596/2014 on market abuse (“MAR”), which is implemented into Icelandic law with the act on measures against market abuse No 60/2021.

Press Release Supporting Nickel Downstream Industry in Indonesia, Danantara Indonesia and INA Announce Strategic Partnership with Eramet Jakarta, 28 May 2025 – The Indonesia Investment Management Agency, Danantara Indonesia, and the Indonesia Investment Authority (INA) announced the signing of a Memorandum of Understanding (MoU) with French mining company Eramet to explore the establishment of a strategic investment platform in the nickel sector, spanning upstream to downstream operations. The signing was witnessed in person by the President of the Republic of Indonesia Prabowo Subianto, and the President of France Emmanuel Macron, at the State Palace in Jakarta on Wednesday (28/052025). This partnership aims to develop a sustainable and integrated electric vehicle (EV) battery raw materials ecosystem in Indonesia. The parties will conduct...

The Board of Directors of Havila Kystruten AS hereby gives notice of the AnnualGeneral Meeting. The meeting will take place on Thursday, June 12th, 2025 at10:00 CEST. The Annual General Meeting will be held as a digital meeting with electronicvoting via Lumi platform. It is also possible to cast votes or give proxyauthorizations in advance. Notice of the Annual General Meeting together withall relevant documents is available at www.havilavoyages.com/nb/ir(http://www.havilavoyages.com/nb/ir). Further information can be found in the notice of the Annual General Meetingwhich is attached hereto. Contacts: Chief Executive Officer: Bent Martini, +47 905 99 650 Chief Financial Officer: Aleksander Røynesdal, +47 413 18 114AttachmentNotice of Annual General Meeting_2025_Havila Kystruten AS

        Pharma Equity Group A/S Launches New Strategy to Drive Growth and Shareholder Returns   28 May 2025Announcement no. 7    Pharma Equity Group (PEG) today announces the launch of a transformative investment strategy aimed at accelerating growth, diversifying its portfolio across Pharma and Medical Devices, including MedTech, and enhancing long-term shareholder returns. Central to this strategic launch is the contemplated establishment of a dedicated Investment Committee (IC) to ensure rigorous evaluation and strategic alignment of all investment activities. This new strategy follows PEG’s implementation earlier this year of a new organizational structure, which supports PEG in its future role as a focused investment company, while designating Reponex Pharmaceuticals A/S as a portfolio company dedicated...